Quick Facts

• Colorectal cancer is now the leading cause of cancer death in adults under 50, with rates expected to double by 2030
• Harvard researchers discovered that E. coli bacteria produce colibactin, a toxin that damages DNA and creates mutations found more often in younger cancer patients
• About 80% of colorectal cancers lack genetic explanations, suggesting environmental factors like gut bacteria disturbances may be key drivers

Scientists are zeroing in on gut bacteria as a potential culprit behind the alarming rise of colorectal cancer in young adults. New research reveals that common bacteria in the digestive system produce toxins that damage DNA in ways that match cancer patterns seen in younger patients.

The numbers paint a stark picture. Today, 1 in 5 colorectal cancer diagnoses occurs in someone under 55. The disease has become the leading cause of cancer-related death in people under 50 – a dramatic shift from previous generations.

Harvard researchers made a breakthrough discovery in December 2025, identifying the exact structure of DNA damage caused by colibactin, a toxin produced by E. coli and other gut bacteria. The study, published in Science, found that specific mutations linked to this toxin appear more frequently in tumors from younger patients.

“The way I think of it is, it’s our soil; it’s a very important part of our interface with the world,” said Dr. Marshall, a researcher studying the microbiome connection. “What I think is that we have somehow altered the soil in some way so that it’s now causing this phenomenon of colon cancer.”

The timing adds another clue to the puzzle. E. coli bacteria are most abundant in infant gut microbiomes, which aligns with the early-life window when environmental risk factors for colorectal cancer are thought to take hold.

Genetics explain only about 20% of colorectal cancer cases. The remaining 80% point to environmental factors, with the gut microbiome emerging as a prime suspect. Chemicals in processed foods and household products may strip away the protective mucus layer lining the gut, creating conditions for harmful bacterial overgrowth.

Dr. Jin, an oncologist at Ohio State University, notes that younger patients face additional challenges. “Even though we treat young patients with more aggressive chemo – more chemo or more surgery – patients’ outcomes are not necessarily better,” Jin said.

The American Cancer Society projects 108,860 new colorectal cancer cases in 2026, with about 55,230 deaths. Death rates among adults aged 20-44 rose continuously from 1999 to 2023, particularly in the 35-44 age group.

Screening guidelines have already shifted in response. The recommended starting age dropped from 50 to 45 in recent years. Some experts advocate for screening at age 40 to catch more early-onset cases.

Diagnostic delays remain a problem for younger patients, who wait an average of 7 months from first symptoms to treatment compared to 1 month for patients over 50. This delay can mean the difference between early and late-stage diagnosis.

The research challenges are significant. Scientists must untangle complex interactions between different microbiomes in the mouth, stomach, and gut. While they have suspicions about mechanisms that damage the digestive system, isolating specific cancer triggers remains difficult.

Read more: Scientists search the microbiome for clues to the rise in colorectal cancers